Quarterly report [Sections 13 or 15(d)]

Business Combination - Intangible Assets Acquired (Details)

v3.25.2
Business Combination - Intangible Assets Acquired (Details) - USD ($)
6 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Indefinite-Lived Intangible Assets [Roll Forward]    
Impairment $ 0  
Goodwill [Roll Forward]    
Combination Date Fair Value 11,812,476  
Impairment 0  
Carrying Value 12,458,383 $ 12,458,383
Pharmagesic    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   69,500,000
Translation Adj   (196,418)
Carrying Value 69,303,582 69,303,582
Goodwill [Roll Forward]    
Combination Date Fair Value   12,493,727
Translation Adj   (35,344)
Carrying Value 12,458,383 12,458,383
Pharmagesic | Halneuron for Cancer Related Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   59,900,000
Translation Adj   (169,287)
Carrying Value 59,730,713 59,730,713
Pharmagesic | Halneuron for Chemotherapy Induced Neuropathic Pain    
Indefinite-Lived Intangible Assets [Roll Forward]    
Combination Date Fair Value   9,600,000
Translation Adj   (27,131)
Carrying Value $ 9,572,869 $ 9,572,869